Latest Breaking News On - Toronto stock venture exchange - Page 4 : comparemela.com

Theralase Technologies Inc : Theralase Releases 1Q2023 Interim Financial Statements

TORONTO, ON / ACCESSWIRE / May 30 2023 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development

United statesSan franciscoRoger dumoulin whiteArkady mandelClean technologyAmerican urology associationCompany photo dynamic compoundsTheralase technologies incCompany antiVenture exchangeRegulation services providerTechnologies incCompany board of directorsTheralase technologies inc viewInternational bladder cancer groupAmerican society of clinical oncology

Theralase(R) Releases Corrected and Restated Press Release for 1Q2023 Interim Financial Statements

Theralase(R) Releases Corrected and Restated Press Release for 1Q2023 Interim Financial Statements
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesRoger dumoulin whiteArkady mandelCompany antiClean technologyOntario securities commissionTechnologies incVenture exchangeAmerican urology associationRegulation services providerToronto stock venture exchangeCompany board of directorsToronto stock exchange ventureTheralase technologies incInternational bladder cancer group

Theralase(R) Releases Corrected and Restated Press Release for 1Q2023

Theralase(R) Releases Corrected and Restated Press Release for 1Q2023 .

United statesArkady mandelRoger dumoulin whiteToronto stock venture exchangeCompany board of directorsToronto stock exchange ventureCompany annual meeting onNews networkDevelopment expensesLife sciencesCompany antiOntario securities commissionClean technologyTechnologies incReleases correctedRestated press release

Theralase(R) Appoints Roger DuMoulin-White as President and Chief Executive Officer

25.05.2023 - TORONTO, ON / ACCESSWIRE / May 24, 2023 / Theralase® Technologies Inc. ( Theralase® or the Company ) (TSXV:TLT) (OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light-activated Photo Dynamic . Seite 1

Matthew perratonToronto stock venture exchangeCompany board of directorsOntario securities commissionCompany annual meeting onSettlement agreementAnnual meetingInvasive bladder cancerTheralase technologies

Theralase(R) Appoints Roger DuMoulin-White as President and Chief Executive

Theralase(R) Appoints Roger DuMoulin-White as President and Chief Executive .

United statesMatthew perratonArkady mandelRoger dumoulin whiteCompany annual meeting onCompany pdcsOntario securities commissionCompany board of directorsRegulation services providerNews networkVenture exchangeTechnologies incToronto stock venture exchangePhoto dynamic compoundsChief executive officerChief scientific officer